PMC:7534795 / 5463-5691 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T52","span":{"begin":182,"end":190},"obj":"Disease"}],"attributes":[{"id":"A52","pred":"mondo_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"kurt, \u0026 Cooper Jr., 2020; Rizk et al., 2020)\nAnti-TNFα • Infliximab, adalimumab, etanercept, golimumab, certolizumab as TNFα neutralizing therapies suggested as potential agents for COVID-19 hyperinflammatory state which may ame"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T48","span":{"begin":81,"end":91},"obj":"Chemical"}],"attributes":[{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_4875"}],"text":"kurt, \u0026 Cooper Jr., 2020; Rizk et al., 2020)\nAnti-TNFα • Infliximab, adalimumab, etanercept, golimumab, certolizumab as TNFα neutralizing therapies suggested as potential agents for COVID-19 hyperinflammatory state which may ame"}

{"project":"2_test","denotations":[{"id":"33031856-32297796-84038803","span":{"begin":20,"end":24},"obj":"32297796"},{"id":"33031856-32696108-84038804","span":{"begin":39,"end":43},"obj":"32696108"}],"text":"kurt, \u0026 Cooper Jr., 2020; Rizk et al., 2020)\nAnti-TNFα • Infliximab, adalimumab, etanercept, golimumab, certolizumab as TNFα neutralizing therapies suggested as potential agents for COVID-19 hyperinflammatory state which may ame"}

{"project":"LitCovid-PubTator","denotations":[{"id":"160","span":{"begin":50,"end":54},"obj":"Gene"},{"id":"161","span":{"begin":120,"end":124},"obj":"Gene"},{"id":"191","span":{"begin":182,"end":190},"obj":"Disease"}],"attributes":[{"id":"A160","pred":"tao:has_database_id","subj":"160","obj":"Gene:7124"},{"id":"A161","pred":"tao:has_database_id","subj":"161","obj":"Gene:7124"},{"id":"A191","pred":"tao:has_database_id","subj":"191","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"kurt, \u0026 Cooper Jr., 2020; Rizk et al., 2020)\nAnti-TNFα • Infliximab, adalimumab, etanercept, golimumab, certolizumab as TNFα neutralizing therapies suggested as potential agents for COVID-19 hyperinflammatory state which may ame"}